Stem Cell Therapy for Type 2 Diabetes Mellitus

Clinical trial NCT01142050 · UNKNOWN

Trial details

NCT number: NCT01142050
Sponsor: Cellonis Biotechnology Co. Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2010-08-01
Primary completion: 2011-08-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.